TB 2016, 16-17 July 2016, Durban, South Africa
This meeting incorporates the biannual SA TB Conference.
Reports in this issue are:
- Universal treatment of multi-drug resistant TB is possible within current budgets with generic production
- Shortened nine-month MDR-TB treatment works well in children and adolescents
- Levofloxacin: safety and tolerability in HIV positive and negative children treated for MDR-TB